McKinsey & Company Settles Lawsuit
McKinsey & Company agrees to nationwide $573 million settlement.
Subscriber Benefit
As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe NowIndiana is receiving $12.5 million in a settlement from McKinsey & Co., which resolves investigations into the company’s efforts working for opioid manufacturers. Attorney General Todd Rokita says it is the first multi-state opioid settlement to result in large payments to states to address the opioid epidemic.
Rokita says the settlement filing outlines how McKinsey spurred the opioid crisis by selling marketing schemes and consulting services to opioid manufacturers, including Purdue Pharma, to encourage doctors to over-prescribe OxyContin.
“We owe it to Hoosier families to hold those responsible for this crisis accountable and deliver the justice they deserve. I want to thank the attorneys in my office who have worked tirelessly to reach this historic settlement, which will bring substantial and immediate relief to communities across the state,” said Rokita.
Rokita says Indiana’s share of the $573 million settlement will be used for prevention, education and treatment efforts. The settlement also calls for McKinsey to stop advising companies on certain Schedule II and III narcotics.
“From the first day of my administration, I made combatting the drug epidemic a top priority, and that includes holding accountable those who created and fueled this crisis,” Governor Eric Holcomb said in a statement. “I want to thank the Attorney General and his office for their work on this settlement that will help fund prevention, education and treatment efforts. No amount of money can undo the devastating toll inflicted by the opioid epidemic, but this is another step toward helping Hoosier families recover from this national crisis.”
Indiana was joined in the settlement by 46 other states, Washington, D.C. and five U.S. territories.